Fresh analysis indicates that individuals who discontinue popular weight-loss injections like semaglutide or tirzepatide tend to recover reduced body mass at a significantly accelerated pace than those who stop conventional diet and exercise programs.
Published data in a leading health publication shows that while obese individuals can lose a large proportion of their total mass while undergoing treatment, the weight is regained at an estimated rate of 0.8 kg per month once they quit.
"Users using such medications must be informed of the risk of rapid weight regain when the treatment concludes," cautioned lead investigator Dr. Susan Jebb.
This pace of recovery implies a reversion to original mass within about one and a half years.
Comparing Therapies
The analysis, which looked at dozens of studies involving over 9,000 of participants, contrasted the outcomes of these new drugs with older methods.
Scientists emphasize that individuals who shed pounds through dieting usually have a more gradual creep back—around 0.1 kg a month—after stopping.
The Reason for the Quick Rebound
Doctors propose the mechanism of the jabs explains the accelerated weight return.
These medications imitate a body's own chemical called GLP-1, which controls feelings of fullness.
"Artificially providing the hormone levels several times higher than normal could lead to the body to produce less of its endogenous GLP-1, and may also diminish responsiveness to its effects," said Dr. Adam Collins, a nutrition researcher.
"Stopping of this medication results in appetite is no longer kept in check, making binge eating a significant risk."
A Chronic Disease?
Health authorities suggest the jabs for individuals with obesity-related medical conditions, accompanied by recommended lifestyle changes.
Many experts argue that, given the high risk of weight regain, the therapy might need to be life-long.
This view is reinforced by pharmaceutical companies, who state that the results "emphasize the persistent nature of excess weight," comparing it to managing conditions like diabetes.
User Testimonies
Individuals who have discontinued the medication report a sudden resurgence of cravings.
"I experienced a switch activating and you become extremely hungry," recalled one woman.
The struggle is exacerbated if patients have not adopted lasting lifestyle or habit changes during therapy.
Widespread Adoption
Survey data show that millions of adults in the UK have used these injections in the last 12 months, with interest continuing to grow.
- Adoption is more common among women compared to males.
- The middle-aged age group shows the highest usage rates.
- A large proportion access the drugs through private healthcare rather than the NHS.
Ultimately, researchers emphasize that while the jabs are effective agents for shedding pounds, they are not a standalone fix and lasting health benefits likely depends on integrated lifestyle management.
